Coronavirus Correction: Could This Stock Market Crash Be Worse Than the 2008 Crash?

As the coronavirus correction continues, here are reasons why you shouldn’t treat this meltdown as a repeat of the financial crisis of 2008.

Just a month ago, investors were shrugging off the coronavirus correction, as the outbreak was mostly limited to China.

What a difference a month makes.

We’re now amid a global pandemic. Now that the TSX Index has plummeted 35%, with the S&P 500 following closely behind, we’re not only hearing about a recession from the talking heads on the Street. We’ve begun to hear some folks in the mainstream financial media bring up the thought of a depression — something we’ve not had in nearly a century.

The U.S. Treasury Secretary recently warned that a lack of fiscal action could result in a staggering 20% unemployment rate. That’s in the ballpark of the 25% global peak unemployment rate during 1933. So, it’s understandable that investors are concerned, but they still shouldn’t follow the herd by panic selling.

Coronavirus correction: Don’t expect a repeat of 2008

A depression is a genuinely terrifying concept for investors. In such a worst-case scenario, the “luxury” of a sharp rebound that followed the Great Recession’s crash of 2008 may not be in the cards.

As such, it’s only prudent not to expect this market crash to be a carbon copy of what happened 12 years prior. The circumstances are entirely different, and the fate of the market depends on the outcome of extremely uncertain contingent events.

A vaccine or life-saving treatment could send this market on a rally that Wall Street has never seen the likes of. Heck, the recession we’re falling into might even be milder than the one suffered during the financial crisis, depending on the events that unfold over the coming months.

Volatility goes both ways. You shouldn’t feel obliged to sell after a 35% drop, because most of the damage may already be in the rear-view mirror.

In the meantime, expect more circuit-breaking down days until a promising development happens or the infection curve has a chance to flatten.

Few things are more unpredictable than biology

The magnitude of uncertainty on Bay and Wall Street has arguably never been this high. And as you’re probably aware, there’s nothing investors hate more than uncertainty.

Nobody knows when the coronavirus correction will run its course or when an effective treatment or vaccine will be developed. Some pundits believe we’re a year (or more) away, but some companies, like Regeneron, may be well ahead of schedule and could have something promising by summer.

Still, when it comes to biology, you’re best off not trying to make predictions.

Not even the best epidemiologists in the world can give you an accurate timeline of what’s going to happen with the virus or when a treatment will be readily available. Many of them will tell you they’re not quite sure, because that’s the cold, hard truth.

A biological breakthrough could happen at any time. Or it may not happen for a prolonged period.

When it comes to biology, the uncertainty couldn’t be greater, making a biological crisis an extremely unpredictable beast that one should not attempt to tame. And you shouldn’t let it derail your long-term investment goals if you’re still on track.

Coronavirus correction: Is this biological crisis worse than the financial crisis?

Just because a few folks are bringing up the word depression does not mean you should panic-sell everything for fear that we’ll fall into a +80% crash that could take generations to recover.

A bet on the outcome of a depression is essentially a bet that the world will fail to beat the invisible enemy that is the coronavirus — a bet I wouldn’t make given the world is throwing in everything but the kitchen sink to fight it.

Yes, a pandemic is scary, and optimism (and liquidity) has dried up of late. But that doesn’t mean good things can’t happen after the barrage of negatives that have plagued this year.

Foolish takeaway

The magnitude of fiscal stimulus could be unprecedented, and it could avert an economic disaster. Given “too little” stimulus has more dire consequences than having “too much,” it may be a better idea to be a buyer than a seller in these uncertain times.

As to whether this coronavirus crash is worse than the 2008 crash, we’ll only know after this is all over. However, I’d say a biological crisis has far more unknowns than a financial crisis.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Investing

dividend growth for passive income
Dividend Stocks

Buy the Dip: This Dividend-Growth Giant Just Dropped 14%

This top TSX dividend-growth stock now looks interesting.

Read more »

Canadian investor contemplating U.S. stocks with multiple doors to choose from.
Dividend Stocks

Enbridge vs. Telus: Which Is the Better Dividend Stock to Own Through 2030?

Enbridge and Telus have been popular because of their attractive dividend payouts. But their dividend stories now look quite different.

Read more »

holding coins in hand for the future
Energy Stocks

2 Dividend Stocks to Hold in a TFSA for 20 Years

Decades of dividend growth have driven these stocks higher over the long run.

Read more »

money goes up and down in balance
Energy Stocks

If Your GIC Is Maturing This Year, Don’t Wait to Build the Next Income Stream

A maturing GIC can lock you into much lower future income, so long-term money may need a growing dividend instead.

Read more »

space ship model takes off
Investing

MDA vs. SpaceX: How This Canadian Space Stock Can Still Compete

MDA Space (TSX:MDA) stock looks like a great supplement to Space Exploration Technologies (NASDAQ:SPCX).

Read more »

leader pulls ahead of the pack during bike race
Dividend Stocks

Is Your TFSA Ahead of or Behind the $109,000 Milestone?

Focus on consistently saving and investing for compounding growth rather than the milestone alone.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Leaving $20,000 in Cash for 10 Years Could Cost You $23,000 in Growth

Doing nothing with long-term cash can quietly cost you tens of thousands in missed compounding.

Read more »

woman looks at iPhone
Dividend Stocks

What’s Going on With BCE’s Dividend?

BCE dividend stock news: leverage falls to 3.7 times, free cash flow tops $1 billion, and management confirms payouts through…

Read more »